Results 21 to 30 of about 33,351,014 (255)

Spherical harmonics coeffcients for ligand-based virtual screening of cyclooxygenase inhibitors [PDF]

open access: yes, 2011
Background: Molecular descriptors are essential for many applications in computational chemistry, such as ligand-based similarity searching. Spherical harmonics have previously been suggested as comprehensive descriptors of molecular structure and ...
Angioni, Carlo   +25 more
core   +2 more sources

Selecting Machine-Learning Scoring Functions for Structure-Based Virtual Screening [PDF]

open access: yes, 2020
Interest in docking technologies has grown parallel to the ever increasing number and diversity of 3D models for macromolecular therapeutic targets. Structure-Based Virtual Screening (SBVS) aims at leveraging these experimental structures to discover the
Pedro, Ballester
core   +1 more source

CarbonAI, A Non-Docking Deep learning based small molecule virtual screening platform [PDF]

open access: yes, 2023
Structure-based virtual screening is a promising in silico technique that integrates computational methods into drug discovery. The most extensively used method in structure-based virtual screening is molecular docking.
Xiaojie, Wang   +11 more
core   +1 more source

Discovery of Novel HPK1 Inhibitors Through Structure-Based Virtual Screening

open access: yesFrontiers in Pharmacology, 2022
Hematopoietic progenitor kinase (HPK1) is a negative regulator of T-cell receptor and B-cell signaling, which has been recognized as a novel antitumor target for immunotherapy.
Huizhen Ge   +5 more
doaj   +1 more source

Comparative analysis of virtual screening approaches in the search for novel EphA2 receptor antagonists [PDF]

open access: yes, 2015
The EphA2 receptor and its ephrin-A1 ligand form a key cell communication system, which has been found overexpressed in many cancer types and involved in tumor growth.
PALA, Daniele   +16 more
core   +1 more source

Structure-Based Virtual Screening: From Classical to Artificial Intelligence

open access: yesFrontiers in Chemistry, 2020
The drug development process is a major challenge in the pharmaceutical industry since it takes a substantial amount of time and money to move through all the phases of developing of a new drug.
Eduardo Habib Bechelane Maia   +5 more
doaj   +1 more source

Fuzzy virtual ligands for virtual screening [PDF]

open access: yes, 2009
A new method to bridge the gap between ligand and receptor-based methods in virtual screening (VS) is presented. We introduce a structure-derived virtual ligand (VL) model as an extension to a previously published pseudo-ligand technique [1]: LIQUID [2 ...
Löwer, Martin   +7 more
core   +1 more source

A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods

open access: yesJournal of Genetic Engineering and Biotechnology, 2020
Background The COVID-19 pandemic caused by SARS-CoV-2 has shown an exponential trend of infected people across the planet. Crediting its virulent nature, it becomes imperative to identify potential therapeutic agents against the deadly virus.
Ekampreet Singh   +7 more
doaj   +1 more source

NeuralDock: Rapid and Conformation-Agnostic Docking of Small Molecules

open access: yesFrontiers in Molecular Biosciences, 2022
Virtual screening is a cost- and time-effective alternative to traditional high-throughput screening in the drug discovery process. Both virtual screening approaches, structure-based molecular docking and ligand-based cheminformatics, suffer from ...
Congzhou M. Sha   +6 more
doaj   +1 more source

Discovery of New AKT1 Inhibitors by Combination of In silico Structure Based Virtual Screening Approaches and Biological Evaluations [PDF]

open access: yes, 2019
AKT1 is emerging as a useful target for treating cancer. Herein, we discovered a new set of ligands that inhibit the AKT1, as shown by in vitro binding and cell line studies, using a newly designed virtual screening protocol that combines structure-based
Denisse A., Gutierrez   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy